Abstract:Abstract Background: Benzene and ethylene oxide are considered carcinogenic to humans by International Agency for Research on Cancer based on experimental animal studies whereas acrolein and crotonaldehyde are considered weak carcinogens. They are present in cigarette smoke and other environmental sources. Epidemiological data linking them to lung cancer in humans have been lacking. Methods: A nested case-control study of lung cancer was conducted within the Shanghai Cohort Study, a population-based prospective cohort of 18,244 Chinese men aged 45–64 years at enrollment during 1986–1989. In addition to in-person interviews for information on use of tobacco and alcohol, usual diet, and medical history, each participant provided a 10-ml blood sample and one single void urine sample at baseline. Annual follow-ups to each surviving subject were conducted to identify incident cancer cases and death. The present study included 96 cases who never smoked and 343 cases who smoked cigarettes at baseline. One control for each case was randomly chosen among cohort participants. The control was matched to the index case by age (±2 years), date of urine collection (±1 month), neighborhood of residence, and smoking status. We quantified urinary mercapturic acid metabolites for benzene [S-phenyl mercapturic acid (SPMA)], ethylene oxide [2-hydroxyethyl mercapturic acid (HEMA)], acrolein [3-hydroxypropyl mercapturic acid (HPMA)], and crotonaldehyde [4-hydroxybut-2-yl mercapturic acid (HBMA)] for all study subjects. For current smokers, we also determined urinary levels of cotinine and its glucuronides (total cotinine), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides (total NNAL), and r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and its glucuronides (PheT), validated biomarkers of uptake and metabolism of nicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and polycyclic aromatic hydrocarbons (PAH), respectively, for current smokers. The odds ratio (OR) and 95% confidence interval (CI) for lung cancer with urinary biomarkers were estimated using an unconditional logistic regression method. Results: Among current smokers, all measured mercapturic acid metabolites were statistically significantly higher in cases than controls. Compared with the lowest quartile, ORs (95% CIs) of lung cancer for highest quartile were 1.80 (1.14–2.85) for SPMA, 2.13 (1.34–3.37) for HEMA, 2.00 (1.25–3.20) for HPMA, and 1.95 (1.22–3.12) for HBMA (all P's for trend <0.01). Further adjustment for urinary total cotinine, total NNAL, and PheT significantly attenuated and resulted in a null association between all mercapturic acid metabolites and lung cancer risk (all P's for trend >0.50). Among never smokers, cases showed elevated levels of SPMA, but similar levels of HEMA, HPMA, and HBMA, compared with controls. OR for lung cancer was 2.11 (95% CI 1.05–4.23) for highest tertile of SPMA (P for trend = 0.026). There was no statistically significant association between urinary HEMA, HPMA or HBMA and lung cancer risk among never smokers. Conclusion: Urinary SPMA, a mercapturic acid metabolite for benzene, is statistically significant associated with lung cancer risk among never smokers whereas this positive association among current smokers could be largely explained by urinary biomarkers for nicotine, NNK and PAH, established risk factors for lung cancer for smokers in the present study population. Mercapturic acid metabolites for acrolein, crotonaldehyde, and ethylene oxide are not independent predictors for lung cancer for both smokers and nonsmokers. Citation Information: Cancer Prev Res 2011;4(10 Suppl):A6.

Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers

Urinary Levels of Cigarette Smoke Constituent Metabolites Are Prospectively Associated with Lung Cancer Development in Smokers

Genetic Variability in the Metabolism of the Tobacco‐specific Nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK) to 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL)

Assessing Exposure to Tobacco-Specific Carcinogen NNK Using Its Urinary Metabolite NNAL Measured in US Population: 2011–2012

Exposure to Tobacco-Specific Carcinogen NNK in US Population (NHANES 201112): Its Urinary Metabolite NNAL Concentration and Estimated Dose

Abstract 4652: Urinary levels of the tobacco-specific carcinogen N′-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers in the Shanghai Cohort Study

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Tobacco-specific N-nitrosamine Exposures and Cancer Risk in the Shanghai Cohort Study: Remarkable Coherence with Rat Tumor Sites.

Urinary Levels of Volatile Organic Carcinogen and Toxicant Biomarkers in Relation to Lung Cancer Development in Smokers.

Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study

Analysis of urinary tobacco-specific nitrosamine 4- (methylnitrosamino)1-(3-pyridyl)-1- butanol (NNAL) and HPV infection in American women: National health and nutrition examination survey

Abstract 863: Urinary Levels of a Polycyclic Aromatic Hydrocarbon Metabolite in Relation to Lung Cancer Development in Cigarette Smokers of the Shanghai Cohort Study

Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014)

Genetic Variability In Tobacco-Specific Nitrosamine Nnk To Nnal Metabolism

The relationship between consumption of nitrite or nitrate and risk of non-Hodgkin lymphoma

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Intake of tobacco nitrosamines of smokers in various provinces of China and their cancer risk: A meta-analysis

Tobacco‐specific N‐nitrosamines and Polycyclic Aromatic Hydrocarbons in Cigarettes Smoked by the Participants of the Shanghai Cohort Study

Abstract A6: Urinary Levels of Volatile Organic Carcinogens and Toxicant Biomarkers in Relation to Lung Cancer Development in Both Smokers and Nonsmokers: the Shanghai Cohort Study

NNK-induced DNA Damage As Measured by the Comet Assay is a Marker of Lung Cancer Risk

Concentrations of Cotinine and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in US Non-Daily Cigarette Smokers